Sichuan Cancer Hospital And Research Institute

This study tested a three-part treatment for people with advanced bile duct cancer that had worsened after standard chemotherapy. The treatment combined a targeted drug (apatinib), an immunotherapy (PD-1 antibody), and a procedure that delivers chemotherapy directly to the liver …

This study looked at whether adding the drug aprepitant to the usual two anti-nausea medicines can better prevent nausea and vomiting caused by chemotherapy in people with gynecologic cancers like ovarian, cervical, and endometrial cancer. 143 patients took part. The goal was to …